Table 1.

Basic characteristics of the patients.

Age (mean ± SD) (year)	36 ± 9.61
Gender:
Female	85 (77%)
Male	26 (23%)
Employment status:
Employed	52 (46%)
Unemployed	62 (54%)
Education:
Without academic degree	25 (22%)
With academic degree	89 (78%)
EDSS (mean ± SD)	2.99 ± 1.80
MS duration (mean ± SD) (year)	8.31 ± 5.91
MS type:
RR	89 (80%)
Progressive (PP, SP)	23 (20%)
MS medication:
Interferon Beta-1A (intramuscular)	15 (13.8%)
Interferon Beta-1A (subcutaneous)	9 (8.3%)
Interferon Beta-1B	4 (3.7%)
Glatiramer acetate	18 (16.5%)
Fingolimod	9 (8.3%)
Dimethylfumarat	5 (4.6%)
Teriflunamide	2 (1.8%)
Natalizumab	2 (1.8%)
Rituximab	40 (36.7%)
Ocrelizumab	2 (1.8%)
Cyclophosphamide	2 (1.8%)
Azathioporine	1 (0.9%)